NRXS - NeurAxis, Inc. PEG multiplikatori
NeurAxis, Inc. (NRXS) bolalar gastroenterologik muammolariga qarshi kurashish uchun mo‘ljallangan innovatsion neyrostimulyatsiya tizimlarini joriy etish orqali daromad keltiradi. GURU.Markets platformasida joriy PEG koeffitsiyentini baholagach, biz 0.00 ko‘rsatkichi tegishli indikator bo‘lib xizmat qilishini aniqladik. Yuqori marja va mahsulotning noyobligi etalon pul oqimini ta’minlaydi, ammo sug‘urta to‘lovlarining sekinligi va tadqiqotlar uchun qarz mablag‘lariga bo‘lgan ehtiyoj moliyaviy xatarlarni yuzaga keltiradi.
NeurAxis, Inc. (NRXS) kompaniyasining tahliliy kesimlari
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- bozor kapitallashuvi statistikasi:
- balans bo'yicha xususiy kapital ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati NeurAxis, Inc.|NRXS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti neuraxis.com|NRXS - Kompaniya qarzlari|Sof aktivlarga qarzlar NeurAxis, Inc|NRXS - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari NeurAxis|Oraliq qoplama koeffitsiyenti neuraxis.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
NRXS - Kompaniyaning sof foydasi|Sof foyda prognozi NeurAxis, Inc.|NRXS - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati NeurAxis Inc|NRXS - Narx-foyda va o‘sish multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati NeurAxis, Inc|NRXS - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun foyda NeurAxis|NRXS - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi neuraxis.com|NRXS - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati NeurAxis, Inc.
Kompaniyaning fundamental tahlili:NRXS, NeurAxis Inc.
PEG koeffitsiyenti bozor qiymatining adolatli ekanligini aniqlash uchun joriy P/E koeffitsiyentini foyda o'sish sur'atlari bilan solishtiradi. Birga solishtirganda birdan past qiymatlar aktivning kengayishiga nisbatan qadrsizlanganligini bildiradi. Baholashning foyda dinamikasiga nisbatini tahlil qilish orqali investor tezkor o'sish potentsialini aniqlaydi. NeurAxis, Inc. (NRXS) uchun ushbu tendentsiya pediatrik neyrostimulyatsiyaga nisbatan sug'urta qamrovining kengayishi bilan qo'llab-quvvatlanmoqda. Kattalar terapiyasining kutilayotgan tasdiqlanishi grafikdagi ijobiy dinamikani yanada tezlashtirishi mumkin.
NeurAxis, Inc. kimlar bilan raqobatlashadi
BIIB - O‘sish sur’atiga tuzatilgan narx-foyda|Neurocrine Biosciences Inc - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Regencell Corp RGC|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACAD (acadia-pharm.com)|XENE: PEG multiplikatori|Viking Therapeutics Inc (VKTX) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori SUPN|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CPRX (Catalyst Corp)|PEG multiplikatori DNLI|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati harmonybiosciences.com|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven BHVN|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Amylyx Pharmaceuticals Inc (AMLX)|TRVI: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PRAX (Praxis Corp)|AVXL: PEG multiplikatori|CBLL - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Prothena Corporation plc|O‘sishni hisobga olgan narx-foyda koeffitsiyenti ALEC (Alector Therapeutics)|PEG multiplikatori ANNX|Narx-foyda va o‘sish multiplikatori omeros.com OMER|Neurogene Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati acimmune.com (ACIU)|VYGR - Narxning foydaga va o‘sish sur’atiga nisbati|NMRA (Neumora) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Scilex Holding Co. (SCLX) - Narxning foydaga va o‘sish sur’atiga nisbati|Tevogen Bio Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori ACOG|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CGTX (cogrx.com)|Narxning foydaga va o‘sish sur’atiga nisbati Inhibikase Therapeutics, Inc. (IKT)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Cassava Sciences Inc|Narxning foydaga va o‘sish sur’atiga nisbati Assertio ASRT|COYA: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|VistaGen Therapeutics Inc - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Ovid Therapeutics Inc.|ABOS (Acumen Pharmaceuticals, Inc.) - Narx-foyda va o‘sish multiplikatori|CervoMed, Inc. (CRVO) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Alterity Therapeutics Ltd.|CLNN: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati PepGen Inc. (PEPG)|JUNS - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Grace Tx - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Firefly Neuro|KLTO (anewmeds.com) - Narx-foyda va o‘sish multiplikatori|NeuroSense Therapeutics Ltd. (NRSN) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Reviva Pharmaceuticals Holdings, Inc.|MTVA: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori HSDT|PEG multiplikatori passagebio.com (PASG)|Neuphoria Therapeutics - Narx-foyda va o‘sish multiplikatori|NERV: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Athira Pharma - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Addex Therapeutics Ltd. ADXN|alzamend.com (ALZN) - Narxning foydaga va o‘sish sur’atiga nisbati|CYCN - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori PTIX|KTTA: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori CRGT|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Avenue Therapeutics Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|CARA: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Chromocell Therapeutics - PEG multiplikatori|Eliem Therapeutics (ELYM) - Narx-foyda va o‘sish multiplikatori|ITCI (intracellulartherapies.com) - Narx-foyda va o‘sish multiplikatori|LBPH - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Marinus|O‘sishni hisobga olgan narx-foyda koeffitsiyenti NKGN (NKGen Biotech Corp)|Narxning foydaga va o‘sish sur’atiga nisbati NeuroBo Pharmaceuticals (NRBO)|SAGE (sagerx.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Synaptogenix - Narx-foyda va o‘sish multiplikatori|TRVN: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Anew Medical Inc. WENA|Cerevel Therapeutics (CERE) - Narxning foydaga va o‘sish sur’atiga nisbati
